Xencor, Inc.
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND PSMA

Last updated: 30 Jul 2021

Abstract:

The present invention is directed to heterodimeric antibodies that bind CD3 and PSMA.

Status:

Application

Type:

Utility

Filling date:

7 Dec 2016

Issue date:

9 Jul 2020

Full patent description

Patent application document